By Counterforce Health Team in Revcovi (elapegademase) —

Get Revcovi (Elapegademase) Covered by Cigna in Virginia: Complete Guide with Forms and Appeal Steps

Answer Box: Getting Revcovi Covered by Cigna in Virginia

Yes, Cigna covers Revcovi (elapegademase) for ADA-SCID with prior authorization through Express Scripts/Accredo. Your fastest path: Have your immunologist submit a PA request via Cigna's ePA portal with confirmed ADA-SCID diagnosis, enzyme levels, and specialist oversight documentation. Standard approval takes 72 hours; expedited processing available in 24 hours for urgent cases. If denied, Virginia's external review process through the State Corporation Commission provides independent physician review within 45 days (or 72 hours expedited). Start today: Contact your prescribing specialist to initiate the PA request and enroll in Chiesi Total Care for copay assistance.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Timing and Deadlines
  4. Coverage Criteria
  5. Costs and Financial Assistance
  6. Denials and Appeals
  7. Virginia External Review Process
  8. Specialty Pharmacy Requirements
  9. Troubleshooting Common Issues
  10. FAQ

Coverage Basics

Is Revcovi Covered by Cigna?

Revcovi (elapegademase-lvlr) is covered by Cigna plans but requires prior authorization (PA) as a specialty medication. The drug appears on Cigna's formulary with a (PA) designation, meaning coverage approval is required before your prescription can be filled.

Which Cigna Plans Cover Revcovi?

Coverage applies to:

  • Commercial Cigna health plans
  • Cigna Medicare Advantage plans
  • Most employer-sponsored Cigna plans

Note: Self-funded employer plans may have different requirements. Check your specific plan documents or call the member services number on your ID card.

Specialty Pharmacy Requirements

Cigna requires Revcovi to be dispensed through Accredo Specialty Pharmacy, their preferred specialty pharmacy network. This ensures proper handling, storage, and administration support for this enzyme replacement therapy.

Prior Authorization Process

Who Submits the PA Request?

Your prescribing physician (typically an immunologist, hematologist/oncologist, or ADA-SCID specialist) must submit the prior authorization request. Patients cannot submit PA requests directly.

How to Submit

Method Details Timeline
Electronic (Preferred) EviCore by Evernorth portal, CoverMyMeds, or Surescripts Fastest processing
Phone 1-800-882-4462 Standard 72-hour review
Fax/Mail Cigna Precertification Dept., 1640 Dallas Parkway, Plano, TX 75093 Standard 72-hour review

Required Documentation

Your healthcare provider must include:

  • Confirmed ADA-SCID diagnosis with genetic testing or enzyme level results
  • Documentation of specialist consultation (immunologist/hematologist)
  • Clinical rationale for Revcovi vs. alternative treatments
  • Proposed dosing schedule (typically 0.4 mg/kg weekly, divided into twice-weekly injections)
  • Treatment monitoring plan

Timing and Deadlines

Standard Review Timeline

  • 72 hours for routine prior authorization decisions
  • Clock starts when Cigna receives complete documentation
  • Incomplete requests may cause delays

Expedited Review

  • 24 hours for urgent cases where delays could jeopardize health
  • Your physician must certify medical urgency
  • Available for patients currently on treatment or with life-threatening conditions

How to Check Status

  1. Log into myCigna app or website
  2. Navigate to "Prior Authorization Status"
  3. Call member services at the number on your ID card
  4. Have your physician check the provider portal

Coverage Criteria

Based on available Cigna policies for ADA-SCID treatments, approval typically requires:

Medical Necessity Requirements

  • Confirmed ADA-SCID diagnosis with laboratory evidence (enzyme deficiency or genetic confirmation)
  • Specialist oversight by immunologist, hematologist/oncologist, or physician specializing in primary immunodeficiency
  • Clinical rationale for enzyme replacement therapy
  • Appropriate dosing aligned with FDA labeling (initial 0.4 mg/kg weekly)

Dosing and Administration

  • Initial dosing: 0.2 mg/kg twice weekly (0.4 mg/kg total) for minimum 12-24 weeks
  • Maintenance dosing adjusted based on trough ADA activity (>30 mmol/hr/L target)
  • Intramuscular administration with proper monitoring
Clinician Corner: When writing your medical necessity letter, emphasize the life-threatening nature of ADA-SCID, document any previous treatment failures (including Adagen if applicable), and cite the FDA prescribing information for dosing rationale.

Costs and Financial Assistance

Insurance Coverage Tiers

Revcovi typically falls under Cigna's specialty drug tier, which may involve:

  • Higher coinsurance percentages (often 20-40%)
  • Specialty pharmacy copays
  • Prior authorization requirements

Manufacturer Support Programs

Chiesi Total Care Copay Program:

  • Eligible patients may pay as little as $0 per prescription
  • Requires commercial insurance coverage
  • Cannot be used with government-funded programs (Medicare, Medicaid)
  • Enrollment required through Chiesi Total Care

Patient Assistance Program:

  • Free medication for uninsured/underinsured patients
  • Income eligibility up to 500% of Federal Poverty Level
  • U.S. residency required

How to Apply

  1. Contact Chiesi Total Care directly
  2. Work with your healthcare provider's office
  3. Complete enrollment forms with income documentation

Denials and Appeals

Common Denial Reasons and Solutions

Denial Reason How to Address
Missing ADA-SCID confirmation Submit genetic testing or enzyme level results
Lack of specialist oversight Provide documentation of immunologist consultation
Dosing concerns Reference FDA labeling and clinical guidelines
Site of care issues Clarify intramuscular administration plan
Non-formulary status Request formulary exception with clinical justification

Cigna Internal Appeals Process

First-Level Appeal:

  • Submit within 180 days of denial notice
  • Include additional clinical documentation
  • Decision within 30 days (expedited: 72 hours)

Second-Level Appeal:

  • Available if first appeal denied
  • Independent physician review
  • Same timeline as first-level appeal

Formulary Exception Process

If Revcovi is non-formulary on your specific plan:

  1. Physician calls Cigna Healthcare or submits completed exception form
  2. Must demonstrate previous formulary drug was ineffective or harmful
  3. 72-hour standard review or 24-hour expedited processing
  4. Authorization valid until treatment discontinuation

Virginia External Review Process

If Cigna denies your internal appeals, Virginia law provides independent external review through the State Corporation Commission Bureau of Insurance.

External Review Timeline

Standard Process:

  • 120 days to file after final Cigna denial
  • 5 business days for eligibility review
  • 45 days for Independent Review Organization (IRO) decision
  • Decision is binding on Cigna

Expedited Process:

  • 72 hours for IRO decision
  • Available when delays could jeopardize health
  • Your physician must certify urgency

How to File External Review

  1. Complete Form 216-A (External Review Request)
  2. Submit within 120 days of Cigna's final denial
  3. Include all denial letters and supporting documentation
  4. No fee required for Virginia residents

Contact: Virginia State Corporation Commission Bureau of Insurance at 1-877-310-6560

Tip: Contact the Bureau's Consumer Services staff before filing to ensure you have all required forms and documentation.

Specialty Pharmacy Requirements

Why Accredo?

Cigna requires Revcovi dispensing through Accredo because:

  • Temperature-controlled storage requirements
  • Complex administration training
  • Patient support services
  • Insurance coordination

Working with Accredo

  • Phone: Contact through your Cigna member portal
  • Prior authorization: Accredo coordinates with your physician
  • Delivery: Home delivery or clinical site coordination
  • Support: Patient education and injection training

Troubleshooting Common Issues

Portal Problems

  • myCigna portal down: Call member services directly
  • Provider portal access: Contact Cigna provider services at 1-800-882-4462
  • Missing forms: Download from Cigna provider resources

Communication Delays

  • PA status unclear: Request written confirmation
  • Missing documentation: Ask Cigna specifically what's needed
  • Specialist referral needed: Ensure immunologist/hematologist involvement

Appeals Support

Organizations that can help Virginia residents:

  • Virginia Poverty Law Center Health Assistance Program
  • State Corporation Commission Consumer Services: 1-877-310-6560
  • Virginia Office of the Managed Care Ombudsman

FAQ

How long does Cigna prior authorization take for Revcovi in Virginia? Standard review is 72 hours; expedited review is 24 hours. Timeline starts when Cigna receives complete documentation from your physician.

What if Revcovi is non-formulary on my Cigna plan? Your physician can request a formulary exception within 72 hours (24 hours expedited). They must demonstrate that formulary alternatives were ineffective or harmful.

Can I request an expedited appeal in Virginia? Yes, if delays could jeopardize your health. Both Cigna internal appeals and Virginia external review offer expedited timelines with physician certification of urgency.

Does step therapy apply to Revcovi for ADA-SCID? Step therapy requirements vary by plan. For life-threatening conditions like ADA-SCID, your physician can request step therapy exceptions based on medical necessity.

What happens if Cigna denies my appeal? Virginia residents can file for external review through the State Corporation Commission within 120 days. The independent physician review is binding on Cigna.

How much will Revcovi cost with Cigna coverage? Costs depend on your specific plan's specialty tier structure. Enroll in Chiesi Total Care's copay program to potentially reduce costs to $0 per prescription.

Who can prescribe Revcovi in Virginia? An immunologist, hematologist/oncologist, or physician specializing in ADA-SCID or primary immunodeficiency disorders must prescribe or oversee treatment.

What if I'm currently on Adagen and need to switch? Your physician should reference the conversion guidelines in Revcovi's prescribing information and submit this as part of the medical necessity documentation.

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful, evidence-backed appeals. Their platform analyzes denial letters and plan policies to create targeted rebuttals with the right clinical evidence and procedural requirements for each payer.

When navigating complex prior authorizations like Revcovi, having expert support can make the difference between approval and denial. Counterforce Health specializes in understanding payer-specific workflows and building compelling cases that align with each plan's own coverage criteria.

Sources & Further Reading

Disclaimer: This information is for educational purposes and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with Cigna member services and consult your healthcare provider for medical decisions. For personalized assistance with appeals and coverage issues, contact the Virginia State Corporation Commission Bureau of Insurance at 1-877-310-6560.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.